-
BDTX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Black Diamond Therapeutics (BDTX)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 24.25 mm | 24.25 mm | 24.25 mm | 24.25 mm | 24.25 mm | |
Cash burn (monthly) | 663.33 k | 1.57 mm | 6.04 mm | 6.94 mm | 4.46 mm | |
Cash used (since last report) | 1.86 mm | 4.40 mm | 16.92 mm | 19.42 mm | 12.48 mm | |
Cash remaining | 22.39 mm | 19.85 mm | 7.34 mm | 4.83 mm | 11.77 mm | |
Runway (months of cash) | 33.8 | 12.6 | 1.2 | 0.7 | 2.6 |
13F holders | Current |
---|---|
Total holders | 57 |
Opened positions | 29 |
Closed positions | 46 |
Increased positions | 8 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 110.91 bn |
Total shares | 53.10 mm |
Total puts | 24.80 k |
Total calls | 108.00 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
T. Rowe Price Investment Management | 10.66 mm | $49.68 mm |
BLVGF Bellevue | 8.52 mm | $39.69 bn |
BBBOF BB Biotech | 5.38 mm | $0.00 |
NEA Management | 4.45 mm | $20.73 bn |
New Enterprise Associates 16 | 4.45 mm | $30.03 mm |
Versant Venture Capital VI | 4.33 mm | $14.42 mm |
Ra Capital Management | 2.79 mm | $20.07 mm |
Vestal Point Capital | 2.10 mm | $9.79 bn |
Tang Capital Management | 1.60 mm | $7.47 bn |
Artal | 1.05 mm | $4.88 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Dec 24 | Shannon Campbell | Common Stock | Grant | Acquire A | No | No | 2.5 | 4,500 | 11.25 k | 8,865 |
13 Dec 24 | Prakash Raman | Common Stock | Grant | Acquire A | No | No | 2.5 | 5,150 | 12.88 k | 10,145 |
13 Dec 24 | Behbahani Ali | Common Stock | Grant | Acquire A | No | No | 2.5 | 5,750 | 14.38 k | 63,334 |
20 Sep 24 | Behbahani Ali | Common Stock | Grant | Acquire A | No | No | 4.78 | 3,007 | 14.37 k | 57,584 |
20 Sep 24 | Shannon Campbell | Common Stock | Grant | Acquire A | No | No | 4.78 | 2,354 | 11.25 k | 4,365 |